- Home
- OKYO vs WVVI Comparison
OKYO vs WVVI Comparison
Compare OKYO & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- WVVI
- Stock Information
- Founded
- OKYO 2007
- WVVI 1983
- Country
- OKYO United Kingdom
- WVVI United States
- Employees
- OKYO N/A
- WVVI N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- WVVI Beverages (Production/Distribution)
- Sector
- OKYO Health Care
- WVVI Consumer Staples
- Exchange
- OKYO Nasdaq
- WVVI Nasdaq
- Market Cap
- OKYO 37.0M
- WVVI 31.0M
- IPO Year
- OKYO 2022
- WVVI N/A
- Fundamental
- Price
- OKYO $1.37
- WVVI $5.86
- Analyst Decision
- OKYO Strong Buy
- WVVI
- Analyst Count
- OKYO 1
- WVVI 0
- Target Price
- OKYO $7.00
- WVVI N/A
- AVG Volume (30 Days)
- OKYO 87.4K
- WVVI 5.1K
- Earning Date
- OKYO 05-23-2025
- WVVI 05-20-2025
- Dividend Yield
- OKYO N/A
- WVVI N/A
- EPS Growth
- OKYO N/A
- WVVI N/A
- EPS
- OKYO N/A
- WVVI N/A
- Revenue
- OKYO N/A
- WVVI $39,782,442.00
- Revenue This Year
- OKYO N/A
- WVVI N/A
- Revenue Next Year
- OKYO N/A
- WVVI N/A
- P/E Ratio
- OKYO N/A
- WVVI N/A
- Revenue Growth
- OKYO N/A
- WVVI 1.65
- 52 Week Low
- OKYO $0.81
- WVVI $3.17
- 52 Week High
- OKYO $1.74
- WVVI $6.33
- Technical
- Relative Strength Index (RSI)
- OKYO 53.01
- WVVI 52.12
- Support Level
- OKYO $1.32
- WVVI $5.71
- Resistance Level
- OKYO $1.65
- WVVI $6.09
- Average True Range (ATR)
- OKYO 0.11
- WVVI 0.15
- MACD
- OKYO -0.01
- WVVI -0.01
- Stochastic Oscillator
- OKYO 35.29
- WVVI 77.33
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.